Rating Change
Oppenheimer reiterated its Outperform rating on Guardian Pharmacy Services, Inc. (NYSE:GRDN) on August 07, 2026.
reiterateNYSE:GRDN
Oppenheimer Reiterates Outperform Rating on Guardian Pharmacy Services, Inc. (GRDN)
Oppenheimer reiterated its Outperform rating on Guardian Pharmacy Services, Inc. (NYSE:GRDN) on August 07, 2026.
At publication ·
What changed
Guardian Pharmacy Services, Inc. (NYSE:GRDN) · reiterate
- Firm
- Oppenheimer
- Rating
- Outperform to Outperform
- Price at event
- $43.83
- Market capitalization
- $2.0B
At a glance
Key takeaways
- Oppenheimer reiterated an Outperform rating on Guardian Pharmacy Services (GRDN) on August 7, 2026, with the stock trading at $43.83 and a market capitalization of $2.0 billion.
Market Context
Guardian Pharmacy Services, Inc. operates in the Healthcare sector. The stock currently trades at $43.83 with a market capitalization of $2.0B.
Analyst coverage from Oppenheimer provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Guardian Pharmacy Services, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Guardian Pharmacy Services, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 07, 2026 | Oppenheimer | Outperform | N/A |
| Jun 17, 2026 | Truist Securities | Buy | N/A |
| Jun 17, 2026 | B of A Securities | Buy | N/A |
| May 07, 2026 | Oppenheimer | Outperform | N/A |
| Apr 27, 2026 | B of A Securities | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View GRDN Stock Page
Frequently Asked Questions
What does the Outperform rating mean for GRDN?
A rating of Outperform from Oppenheimer reflects the analyst's outlook on Guardian Pharmacy Services, Inc. (NYSE:GRDN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the GRDN forecast page.